Search

A study conducted at Aarhus University Hospital in Denmark focused on the prognostic capabilities of the tricuspid annular plane systolic excursion (TAPSE) to pulmonary arterial systolic pressure (PASP) ratio in patients with acute pulmonary embolism (PE). The research found an inverse association between the TAPSE/PASP ratio and 30-day mortality, with lower ratios indicating increased mortality risk. The study concluded that this ratio may assist in clinical decision-making, especially for intermediate-risk patients where current risk stratification tools have limitations. [Extracted from the article]

A study conducted at University Hospital Ioannina in Greece compared clinical and echocardiographic characteristics between elderly and younger patients with acute pulmonary embolism (PE). The research found that elderly patients with PE had different symptoms, higher levels of biomarkers like D-dimer and troponins, and distinct echocardiographic indices compared to younger patients. The study concluded that there are notable differences in presentation and diagnostic markers between elderly and younger patients with PE. [Extracted from the article]

Researchers at the Subbaiah Institute of Medical Sciences in Karnataka, India, have conducted a study on the different clinical presentations of pulmonary embolism. The study highlights the wide range of symptoms associated with pulmonary embolism, from asymptomatic cases to life-threatening emergencies. Early diagnosis and appropriate treatment are crucial in managing this condition to prevent mortality. The research emphasizes the importance of clinical suspicion and prompt intervention in cases of pulmonary embolism. [Extracted from the article]

A recent study conducted at the Second Hospital of Hebei Medical University explored the causal relationship between matrix metalloproteinases (MMPs) and pulmonary embolism. The research, based on genome-wide association studies, indicated that MMP19 may elevate the risk of pulmonary embolism, while MMP12 could potentially reduce the risk. However, no causal associations were found for other MMPs in relation to pulmonary embolism. The study suggests that measuring MMPs could aid in identifying individuals at higher risk of pulmonary embolism, but further research is necessary for conclusive results. [Extracted from the article]

A study conducted at the University of California Davis examined the differences in testing for pulmonary embolism (PE) among emergency department patients aged 18-49 based on sex and chief complaint. The research found that women were more likely to undergo diagnostic testing for PE than men, despite the disease incidence being higher in men overall. Specifically, female patients with chest pain were significantly more likely to be tested with a D-dimer but less likely to be diagnosed with PE. This study sheds light on the importance of considering patient sex and chief complaint in diagnostic testing for PE. [Extracted from the article]

A patent application by Eximo Medical Ltd. for a "Smart Aspiration System And Laser Activation System" aims to improve the treatment of deadly diseases caused by blood clots in the circulatory system, such as myocardial infarction, stroke, pulmonary embolism, and deep venous thrombosis. The system involves a catheter, canister, pressure source, sensor, and computer system to control aspiration flow rate efficiently during the removal of undesirable intravascular material. This innovative system addresses the limitations of existing vascular treatment systems and offers a promising solution for saving lives of patients suffering from vascular conditions. [Extracted from the article]

A study conducted at Xuzhou Medical University in the People's Republic of China explored the role of platelet-specific TGF-beta 1 in sepsis in mice. The research found that deficiency of platelet-derived TGF-beta 1 inhibited septic thrombosis, prolonged survival time, and could potentially serve as a novel therapeutic target for sepsis treatment. The study was supported by various funding sources and has been peer-reviewed, providing valuable insights into the pathogenesis of sepsis. [Extracted from the article]

A recent study from Abidjan, Republic of Cote d'Ivoire, highlighted the association between Polycystic Ovary Syndrome (PCOS) and Cerebral Venous Sinus Thrombosis (CVST) in women. The study described a case of CVST in a 42-year-old woman with PCOS, obesity, and no recognizable pro-thrombotic disorder. The research emphasized the importance of comprehensive studies to understand the factors contributing to CVST in women with PCOS for effective risk assessment and preventive measures. [Extracted from the article]

Johnson & Johnson announced positive results from the Phase 3 MARIPOSA study, showing that the combination of RYBREVANT(R) (amivantamab-vmjw) plus LAZCLUZE(TM) (lazertinib) improved overall survival in patients with non-small cell lung cancer (NSCLC) with specific mutations. The combination therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to the current standard of care, osimertinib. These findings offer hope for patients with EGFR-mutated NSCLC and provide a new treatment option to extend survival. The safety profile of the combination therapy was generally consistent with individual treatments, with venous thromboembolic events observed and managed with prophylactic anticoagulant medicines. [Extracted from the article]

A patent has been issued for disease-specific and treatment type-specific control of intraluminal ultrasound imaging by Philips Image Guided Therapy Corporation. The system allows for pre-selecting imaging parameters based on the disease type or treatment, enhancing features like stents or thrombi in intravascular ultrasound images. This technology aims to streamline imaging procedures and improve the visualization of specific anatomical features in cardiovascular conditions. [Extracted from the article]

A patent has been issued for insulin formulations and uses in infusion devices by Willow Laboratories Inc. The patent aims to address challenges faced by insulin infusion devices, such as catheter failure and infusion site pain, by developing insulin formulations with improved biochemical properties. The patent describes insulin formulations with adjunctive excipients like hyaluronidase and anti-thrombosis agents, as well as a device for administering insulin with separate reservoirs for insulin and adjunctive excipients. This innovation could potentially improve the quality of life for individuals managing diabetes by providing more reliable and effective insulin delivery systems. [Extracted from the article]

A patent has been issued for a non-foreshortening stent by Vesper Medical Inc., designed to treat conditions such as May-Thurner syndrome and deep venous thrombosis. May-Thurner syndrome is a condition where compression of the left common iliac vein by the right common iliac artery can lead to blood clots and other adverse effects. The stent aims to address limitations of current stenting options, offering improved flexibility and support to prevent further compression. [Extracted from the article]

Researchers at the First Affiliated Hospital of Hebei North University conducted a study on the role of the S100A8 protein in deep vein thrombosis (DVT) development. The study found that S100A8 exacerbates DVT by sustaining local inflammation and thrombus formation in vascular endothelial cells. Blood specimens from patients with DVT and controls were analyzed to investigate the relationship between S100A8 and DVT. The research suggests that targeting S100A8 may be a potential strategy for managing DVT. [Extracted from the article]

A study conducted at Thomas Jefferson University compared outcomes of patients with acute complicated type B aortic dissections repaired using the Zenith dissection endovascular system (ZDES) versus traditional aortic stent grafts. The research found that patients treated with ZDES had fewer post-procedural adverse events and favorable false lumen thrombosis outcomes at 6 and 12 months. While ZDES did not show a statistically significant change in transaortic diameter, further investigation is needed to understand aortic remodeling in the distally stented regions and explore the incidence of endoleaks associated with ZDES for long-term patient outcomes. [Extracted from the article]

A study conducted at the University of the Punjab in Lahore, Pakistan, focused on synthesizing and evaluating the thrombolytic activity of novel pyrazolo[3,4-b]pyridine-4-carbohydrazide derivatives. The research identified compounds 4c and 4d as having significant potential for clinical trials and the development of therapeutics for cardiovascular and thromboembolic conditions. The study was supported by the Higher Education Commission of Pakistan and has been peer-reviewed. For more information, readers can refer to the Journal of Molecular Structure. [Extracted from the article]

A recent study conducted at Fudan University in Shanghai, China, focused on thrombosis events in Chinese patients with newly diagnosed multiple myeloma (NDMM). The research found that patients with NDMM, especially those treated with immunomodulatory drugs (IMiDs), had a high risk of thrombosis. The study included 931 NDMM patients, with 4.51% developing thrombotic events, and concluded that these events did not impact overall survival or progression-free survival. The incidence of thrombosis was higher in patients treated with IMiDs compared to those without, highlighting the importance of monitoring and managing thrombotic risks in this patient population. [Extracted from the article]

A study from Universiti Kebangsaan Malaysia explores the diagnostic challenge of umbilical artery thrombosis (UAT) masquerading as a single umbilical artery (SUA) in prenatal care. The research describes a case of a stillbirth where UAT was mistaken for SUA, highlighting the difficulty in diagnosing UAT radiologically. Early identification of at-risk fetuses is crucial to prevent fetal loss. The study emphasizes the importance of close monitoring and timely interventions in such cases. [Extracted from the article]

A recent study conducted at Vanderbilt University Medical Center explored the factors influencing the choice of initial anticoagulation in hospitalized patients with pulmonary embolism (PE). The research involved qualitative interviews with physicians from various specialties, revealing common barriers and facilitators to guideline-concordant anticoagulation. Themes such as agnosticism towards anticoagulant choice, inertia of learned practice, and institutional culture were identified as key factors influencing anticoagulant selection. The study suggests that future implementation efforts should target these domains to improve guideline adherence in patients with acute PE. [Extracted from the article]

A recent study conducted at the Third Hospital of Hebei Medical University focused on identifying factors associated with preoperative deep venous thrombosis (DVT) in elderly patients with femoral neck fractures. The study found that combining age-adjusted d-dimer levels, platelet distribution width, and other factors improved the ability to predict DVT in these patients. The research concluded that this approach could aid in risk assessment, stratification, and management of DVT in clinical practice. For more information, readers can refer to the BMC Surgery journal article available for free online. [Extracted from the article]

Researchers from the Department of Obstetrics and Gynecology have published new data on the acute management of massive pulmonary embolism in pregnancy. The study highlights the challenges in diagnosing pulmonary embolism during pregnancy due to physiological changes, emphasizing the importance of timely and aggressive management. While thrombolysis is a commonly used treatment option with high maternal and fetal survival rates during pregnancy, other therapeutic options such as thrombectomy should be considered in the postpartum period to avoid life-threatening hemorrhage. The research calls for further work in creating a validated algorithm for diagnosing pulmonary embolism in pregnancy and the postpartum period. [Extracted from the article]

A study conducted by researchers at Sichuan University focused on the impact of calf muscular vein thrombosis (CMVT) on the prognosis of geriatric hip fracture patients postoperatively. The study found that while there was no significant difference in mortality within one year postoperatively between patients with and without CMVT, those with CMVT experienced longer hospital stays, higher rates of postoperative complications, and increased thrombosis progression. The researchers recommended strategies such as close monitoring of thrombosis status, individualized care, and enhanced rehabilitation to optimize outcomes for this patient population. The study was published in BMC Geriatrics and can be accessed for free online. [Extracted from the article]

A recent study conducted at the Valley Vein Health Center in Turlock, California, focused on the incidence and management of venous thromboembolism (VTE) in rural patients undergoing varicose vein treatment. The research found that the incidence of VTE was low, with 45 cases out of 14,172 ultrasound-guided foam sclerotherapy (UGFS) procedures and 4865 radiofrequency ablation (RFA) treatments. Patients with a prior history of deep vein thrombosis (DVT) were at increased risk of developing VTE, and the modified Caprini risk score was identified as a useful tool for risk assessment. The study concluded that prior history of VTE poses a significant risk for recurrence in patients undergoing varicose vein treatments. [Extracted from the article]

Researchers at Southwest Medical University in Luzhou, China, recently reported a case of mechanical thrombectomy (MT) for refractory cerebral venous sinus thrombosis (CVST) in a child with nephrotic syndrome (NS). The 13-year-old boy with NS presented with acute headache and was found to have thrombus in multiple sinuses. After deteriorating on heparin therapy, the child underwent MT and showed improvement within 24 hours, ultimately recovering with normal neurological function. The study suggests that MT may be a viable option for refractory CVST in children with NS. [Extracted from the article]

Recent research from Tabriz University of Medical Sciences explores the association between Vitamin D deficiency and the risk of thrombotic disease. Vitamin D plays a crucial role in maintaining skeletal health and regulating calcium and phosphate metabolism. The study highlights the need for strategies to increase Vitamin D levels through dietary modifications and supplementation to prevent thrombotic events, especially among populations with limited exposure to sunlight. The findings suggest that low serum levels of Vitamin D may correlate with an increased risk of venous thromboembolism, although reported findings remain inconsistent. [Extracted from the article]

The article discusses the FRIENDS-01 clinical trial, which focuses on the treatment of Cancer Therapy Induced Thrombocytopenia (CTIT) using Romiplostim N01 compared to Recombinant Human Interleukin-11. The trial is interventional, in phase 3, and involves a randomized study design with no masking. The study aims to evaluate the efficacy and safety of the two treatments in patients with CTIT, with a primary completion date set for April 21, 2026. The trial is currently not yet recruiting participants, with eligibility criteria including age range, diagnosis of a malignant tumor, and specific platelet count requirements. The study is being conducted in China, with contact information provided for interested participants. [Extracted from the article]

Just-Evotec Biologics Inc. has been issued a patent for aflibercept formulations containing a lysine salt as a tonicifying agent for ophthalmic administration. Aflibercept is a recombinant fusion protein used in the treatment of various eye disorders, including macular edema and age-related macular degeneration. The patent outlines specific formulations of aflibercept with enhanced stability and favorable visual characteristics for intravitreal or topical administration in treating these eye disorders. [Extracted from the article]

Researchers at Second Military Medical University conducted a study on predicting pulmonary embolism (PE) using a machine learning algorithm. The study analyzed 1480 suspected PE patients and found that the random forest (RF) model had the highest efficacy in predicting outcomes, with an AUC of 0.776. The researchers designed a web page for the PE prediction model to aid in early diagnosis and treatment strategies. This study aims to enhance patient outcomes by optimizing the prediction and management of PE. [Extracted from the article]

A recent study conducted at Kyoto University Hospital in Japan focused on a case of Fat Embolism Syndrome (FES) treated with high-dose methylprednisolone. The study involved a 74-year-old woman who experienced acute pulmonary embolism post-orthopedic surgery, with no signs of pulmonary thromboembolism found on contrast computed tomography. Despite initial treatment with norepinephrine and dobutamine, the patient's hemodynamic status did not improve until high-dose methylprednisolone was administered, leading to prompt improvement. The research suggests the potential efficacy of high-dose methylprednisolone in improving hemodynamic status in cases of FES. [Extracted from the article]

Researchers at the Beijing Institute of Technology have developed a new computational thrombosis modeling approach to predict thrombus formation in aortic dissection patients post-stenting. The method utilizes a multiphase porous media theory to enhance predictive accuracy and reduce computational complexity, resulting in improved efficiency and clinical diagnosis capabilities. This study offers valuable insights for optimizing patient recovery and enhancing post-TEVAR prognostic evaluation. [Extracted from the article]

Researchers from Limoges University Hospital conducted a study on the prognostic value of incidental coronary artery calcifications (CAC) in patients undergoing computed tomography pulmonary angiography (CTPA) for suspected pulmonary embolism (PE). The study found that the presence of CAC independently predicted cardiovascular outcomes, including mortality, myocardial infarction, and coronary revascularization. The research suggests that assessing CAC in CTPA for suspected PE could provide valuable prognostic information beyond the initial PE diagnosis. The study was published in The American Journal of Cardiology and was peer-reviewed. [Extracted from the article]

Research from Lugano explores Budd-Chiari syndrome, a rare vascular disorder characterized by hepatic vein obstruction. The study discusses a case of a 26-year-old female with chronic Budd-Chiari syndrome and highlights the possible association with incomplete systemic lupus erythematosus. The importance of close monitoring and timely diagnosis to prevent disease progression is emphasized, with a focus on identifying symptoms of lupus erythematosus. The research underscores the need for further investigation and monitoring in such cases. [Extracted from the article]

A recent study from Ankara, Turkey, explored the prognostic value of total blood count parameter ratios in acute pulmonary embolism (PE). The study focused on the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean-platelet-volume-to-lymphocyte ratio (MPVLR) in 231 adult PE patients. High-risk patients showed elevated NLR and MPVLR, which correlated with ICU admission, intubation, and mortality. The NLR demonstrated the strongest prognostic value, suggesting these markers could improve risk stratification in PE patients. [Extracted from the article]

Researchers at Ghent University have developed a new method for constructing acoustic vulnerability curves in trees to better understand the impact of embolisms during drought. By using acoustic emission analysis, they were able to accurately quantify a tree's vulnerability to embolism formation, enhancing the accuracy of assessing drought stress. This method reduces subjectivity and offers broader insights into tree hydraulics, making it applicable across different species and environmental conditions. The study was published in Tree Physiology by Oxford University Press, and more information can be found by contacting the authors Kaat De Boeck and Kathy Steppe at Ghent University. [Extracted from the article]

Researchers in Esbjerg, Denmark, have conducted a study on atrial fibrillation (AF) and its association with stroke and systemic embolism. The study highlights the importance of balancing the risk of stroke and bleeding in patients with device-detected AF (DDAF) who may benefit from oral anticoagulant treatment. The research emphasizes the need for refining stroke risk assessment in patients with DDAF to optimize treatment strategies. For more information, readers can refer to the Journal of Clinical Medicine. [Extracted from the article]

A recent study from Kayseri City Hospital discusses the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder characterized by hemolytic anemia and thrombosis. The study highlights various treatment options, including stem cell transplantation and monoclonal antibodies approved by the FDA. Additional strategies focus on managing symptoms and complications of PNH, such as blood transfusions and iron replacement therapy. The research emphasizes the importance of anticoagulants and supplementation with folate, iron, and vitamin B12 to reduce the risk of thrombosis and support erythropoiesis. [Extracted from the article]

Researchers at the Indiana Hemophilia and Thrombosis Center published a study on a rare case of acquired factor V inhibitor (AFVwI) in a pediatric patient with venous thrombosis. The 13-year-old female patient with Crohn's Disease and May-Thurner anatomy was successfully treated with anticoagulation therapy, leading to the resolution of AFVwI and normalization of factor V activity. This case highlights the successful management of a pediatric thrombosis case with a rare complication, providing valuable insights for clinical practice. [Extracted from the article]

Vascular Medcure Inc. has been issued a patent for an axial lengthening thrombus capture system, tensioning system, and expandable funnel catheter. The invention aims to remove blood clots from the circulatory system to treat conditions like pulmonary embolism and deep vein thrombosis. The patent describes a capture system that can isolate and remove acute, subacute, and chronic blood clots using a shape memory tubular body and tensioners. This innovative device addresses limitations of current therapies and mechanical debulking techniques, offering a potentially more effective and less invasive treatment option for patients with vascular occlusions. [Extracted from the article]

A patent has been issued for a reduced thrombosis blood pump with a washout bearing by Boston Scientific Scimed Inc. The invention aims to prevent thrombus formation in circulatory support devices like blood pumps by incorporating washout blades to facilitate blood flow. The patent details the design and functionality of the bearing assembly and impeller assembly within the blood pump. This innovation addresses a critical issue in cardiovascular health and medical device technology. [Extracted from the article]

A patent application has been submitted for devices, systems, and methods to evaluate the acuteness of deep vein thrombosis (DVT) caused by blood clots in deep veins. The application aims to improve the accuracy of diagnosing acute versus chronic DVT, as traditional methods relying on patient interviews may be unreliable. The proposed method involves transmitting an ultrasound pulse into the blood clot, analyzing the strength of the ultrasound signal, and determining the acuteness of the clot based on this information. [Extracted from the article]

Researchers from Southwest Medical University in Luzhou, China, conducted a study using bioinformatics to identify biomarkers and immune infiltrates associated with deep vein thrombosis in patients with hip fractures. By analyzing gene expression profiles and immune cell data, they found that inflammatory responses regulated by immune cells like macrophages, B cells, and T cells play a significant role in venous thrombosis. The study highlighted the involvement of signaling pathways like Jak-STAT and HIF-1 in the disease process. This research provides valuable insights into the molecular mechanisms underlying deep vein thrombosis in patients with hip fractures. [Extracted from the article]

A recent study conducted in Richmond, Virginia, focused on the use of anticoagulation assays in pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) treatment. The research found that discordance between activated partial thromboplastin time (aPTT) and anti-Factor Xa (AntiXa) levels is common and can impact patient outcomes. Specifically, titrating heparin based on AntiXa levels during discordant periods was associated with fewer bleeding and clotting events. The study highlights the importance of improved anticoagulation protocols for pediatric ECMO patients. [Extracted from the article]

University of Bahri researchers reported a rare case of a 34-year-old woman with a coexistence of Antiphospholipid Syndrome and Protein S Deficiency, leading to transverse sinus thrombosis. The patient presented with neurological symptoms, joint pain, hyperpigmentation, and a history of recurrent abortions. Tests revealed positive results for various antibodies and proteins associated with the conditions. This case highlights the unusual association between these two hypercoagulable states. [Extracted from the article]

A study conducted at the Medical University of South Carolina examined the utilization of extended pharmacologic venous thromboembolism prophylaxis after colorectal cancer resection. The research found that only 4.7% of patients received prophylaxis, with higher utilization rates in larger hospitals and National Cancer Institute designated hospitals. While prophylaxis was associated with decreased 30-day venous thromboembolism, overall adherence to guidelines was low, indicating a need for further investigation into factors influencing care practices. [Extracted from the article]

A recent study conducted at Tokyo Rinkai Hospital focused on the use of rivaroxaban in treating venous thrombosis in a patient with congenital antithrombin deficiency. The study found that continuous treatment with rivaroxaban led to rapid thrombus resolution and no recurrence for 15 months in a 39-year-old male patient. The research suggests that rivaroxaban may be effective in treating and preventing venous thromboembolism in patients with antithrombin deficiency. [Extracted from the article]

Researchers at the China-Japan Friendship Hospital conducted a study on the diagnostic accuracies of thromboelastography (TEG) combined with traditional coagulation parameters for detecting deep venous thrombosis (DVT) in elderly patients with hip fractures. The study found that TEG, when combined with traditional parameters, enhanced diagnostic capabilities for identifying perioperative thrombosis in this population. The research suggests that TEG could be valuable in establishing a more comprehensive diagnostic and predictive scoring system for DVT in elderly hip fracture patients. [Extracted from the article]

A recent study conducted at State University Campinas in Brazil utilized machine learning and artificial intelligence tools to analyze blood serum metabolites in patients with thromboembolism and antiphospholipid syndrome (APS). The research identified unique metabolic profiles that indicated significant alterations in glycolysis, the TCA cycle, lipid metabolism, and branched-chain amino acid metabolism, shedding light on the complex pathogenesis mechanisms of APS and thromboembolism. The study suggested that histidine, 3-hydroxybutyrate, and threonine could potentially serve as biomarkers to differentiate between APS, thromboembolism, and healthy controls. This research provides valuable insights into the potential use of metabolites as diagnostic tools for these conditions. [Extracted from the article]

A recent study conducted at University Hospital Bonn in Germany focused on assessing hypercoagulability in splanchnic vein thrombosis (SVT) by measuring the enzymes thrombin and activated protein C (APC). The study included 73 patients with SVT, with higher plasma levels of free thrombin and APC observed in patients with myeloproliferative neoplasms (MPNs) compared to healthy controls. The research suggests that APC may be a better biomarker for distinguishing SVT patients with MPNs than conventional indirect thrombin markers, potentially guiding anticoagulant therapy in the future. [Extracted from the article]